Northeast Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-22,365
Closed -$1.61M 201
2022
Q1
$1.61M Sell
22,365
-6,799
-23% -$490K 0.08% 91
2021
Q4
$2.68M Sell
29,164
-12,678
-30% -$1.52M 0.13% 79
2021
Q3
$5.31M Sell
41,842
-707
-2% -$103K 0.28% 56
2021
Q2
$7.08M Buy
42,549
+1,661
+4% +$269K 0.38% 53
2021
Q1
$7.43M Buy
40,888
+808
+2% +$187K 0.44% 49
2020
Q4
$8.01M Buy
40,080
+308
+0.8% +$62.6K 0.49% 43
2020
Q3
$8.72M Sell
39,772
-726
-2% -$154K 0.58% 40
2020
Q2
$7.73M Buy
40,498
+863
+2% +$151K 0.58% 42
2020
Q1
$6.14M Buy
39,635
+5,835
+17% +$679K 0.56% 45
2019
Q4
$2.83M Buy
33,800
+539
+2% +$41K 0.21% 73
2019
Q3
$2.25M Buy
33,261
+198
+0.6% +$13K 0.18% 79
2019
Q2
$2.2M Buy
33,063
+11,833
+56% +$690K 0.17% 78
2019
Q1
$1.18M Buy
21,230
+10,782
+103% +$658K 0.1% 91
2018
Q4
$518K Sell
10,448
-7,641
-42% -$468K 0.05% 107
2018
Q3
$1.56M Buy
+18,089
New +$1.29M 0.12% 88

Other funds holding TDOC

Northeast Investment Management's TDOC Position: Q2 2022 in Review

Northeast Investment Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 22,365 shares — an estimated $1.61M sold.

Northeast Investment Management first reported a position in TDOC in Q3 2018 and held it in 15 quarters. The position peaked at $8.72M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Northeast Investment Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Northeast Investment Management sold 22,365 Teladoc Health shares in Q2 2022, an estimated $1.61M.
  • Northeast Investment Management first reported a position in Teladoc Health in Q3 2018 and held it in 15 quarters.
  • Northeast Investment Management's Teladoc Health position peaked at $8.72M in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Northeast Investment Management's 13F filing for Q2 2022, filed 5 Aug 2022.